Accuri Instruments

Accuri Instruments was a life science research tools company that revolutionized the field of flow cytometry by developing the first "personal" flow cytometer. Their flagship product, the Accuri C6, was designed to be compact, easy to use, and significantly more affordable than traditional flow cytometers, making the technology accessible to individual research labs. The company's innovation focused on simplifying complex fluidics and optical systems into a plug-and-play format that did not require specialized technicians. In 2011, the company was acquired by BD (Becton, Dickinson and Company) for approximately $205 million. Today, its technology remains a core part of BD's life sciences portfolio, continuing to support cell biology and immunology research worldwide.